The Patent Finder

Neuralstem Biopharmaceuticals, Ltd.

Also on record
Records under this name other than patents Neuralstem Biopharmaceuticals, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Neuralstem Biopharmaceuticals, Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,284,539Method for generating dopaminergic cells derived from neural precursors
Formerly held
Term ended
Term ended Oct 9, 2018 · USPTO record
Term endedTerm ended Oct 9, 2018USPTO record
US 6,040,180In vitro generation of differentiated neurons from cultures of mammalian multipotential CNS stem cells
Formerly held
Term ended
Term ended May 7, 2017 · USPTO record
Term endedTerm ended May 7, 2017USPTO record
US 7,544,511Stable neural stem cell line methods
Formerly held
Term ended
Term ended Apr 13, 2017 · USPTO record
Term endedTerm ended Apr 13, 2017USPTO record
US 9,465,025Stable neural stem cell lines
Formerly held
Term ended
Ended no later than Sep 25, 2016 · USPTO record
Term endedEnded no later than Sep 25, 2016USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited